FDA Encourages Recovered Patients to Donate Plasma for Development of Blood-Related Therapies (HERE)
· As part of the all-of-America approach to fighting the COVID-19 pandemic, the U.S. Food and Drug Administration has been working with partners across the U.S. government, academia and industry to expedite the development and availability of critical medical products to treat this novel virus. The FDA is providing an update on one potential treatment called convalescent plasma and encouraging those who have recovered from COVID-19 to donate plasma to help others fight this disease.
The US is Continuing to Lead the Humanitarian and Health Assistance Response to COVID-19 (HERE)
- The U.S. Government is leading the world’s humanitarian and health response to the COVID-19 pandemic even while we battle the virus at home. As part of this comprehensive and generous response from the American people, the U.S. Department of State and the U.S. Agency for International Development (USAID) have now committed nearly $508 million in emergency health, humanitarian, and economic assistance on top of the funding already provided to multilateral and non-governmental organizations that are helping communities around the world deal with the pandemic.
